The temporal relationship of Raynaud's phenomenon and features of connective tissue disease in rheumatoid arthritis

Journal of Rheumatology

Volumn 35, Issue 12, 2008, Pages 2329-2333

  Pope, Janet E ^a,b   Al Bishri, Jamal ^a   Al Azem, Hafsah ^a   Ouimet, Janine M ^a  

^a WESTERN UNIVERSITY   (Canada)

^b ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

Connective tissue disease; Prevalence; Raynaud's phenomenon; Rheumatoid arthritis; Sclerodactyly

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; E NUCLEAR ANTIBODY; RHEUMATOID FACTOR; UNCLASSIFIED DRUG;

ADULT; ARTHROPATHY; ARTICLE; BONE EROSION; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RAYNAUD PHENOMENON; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SCLERODACYTYLY; SCLERODERMA; TELANGIECTASIA;

ARTHRITIS, RHEUMATOID; CONNECTIVE TISSUE DISEASES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RAYNAUD DISEASE;

EID: 57349190187     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.071025     Document Type: Article

References (16)

1. Gordon DA, Hastings DE. Clinical features of rheumatoid arthritis. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 3rd ed. Toronto: Mosby; 2003:765-80.
2. Carroll GJ, Withers K, Bayliss CE. The prevalence of Raynaud's syndrome in rheumatoid arthritis. Ann Rheum Dis 1981;40:567-70.
3. Grassi W, Blasetti P, Core P, Cervini C. Raynaud's phenomenon in rheumatoid arthritis. Br J Rheumatol 1994;33:139-41.
4. Saraux A, Allain J, Guedes C, Baron D, Youinou P, Le Goff P. Raynaud's phenomenon in rheumatoid arthritis. Br J Rheumatol 1996;35:752-4.
5. Bartelink ML, Wollersheim H, van de Lisdonk E, Spruijt R, van Weel C. Prevalence of Raynaud's phenomenon. Neth J Med 1992;41:149-52.
6. Feigenbaum SL, Masi AT, Kaplan SB. Prognosis in rheumatoid arthritits. A longitudinal study of newly diagnosed younger adult patients. Am J Med 1979;66:377-84.
7. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
8. Rychlik-Golema W, Mastej K, Adamiec R. The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases. Int Angiol 2006;25:221-7.
9. Schwarz EM, Looney RJ, Drissi MH, et al. Autoimmunity and bone. Ann NY Acad Sci 2006;1068:275-83.
10. Cotaggio LJ, Evoson G, Harkness JA, Madison PJ. The arthropathy of systemic sclerosis (scleroderma); comparison with mixed connective tissue disease. Clin Exp Rheumatol 1983;1:101-12.
11. Leris RA, Adams JP, Gerber NL, Decker JL, Parsons DB. The hand in mixed connective tissue disease. J Hand Surg Am 1978;3:217-22.
12. Youinou P, Pennec Y-L, Katsikis P, Jouquan J, Fauquert P, Le Goff P. Raynaud's phenomenon in primary Sjögren's syndrome. Br J Rheumatol 1990;29:205-7.
13. Kraus A, Caballero-Uribe C, Jakez J, Villa AR, Alarcón-Segovia D. Raynaud's phenomenon in primary Sjögren's syndrome. Association with other extraglandular manifestations. J Rheumatol 1992;19:1572-4.
14. Leppert J, Åberg H, Ringqvist I, Sörensson S. Raynaud's phenomenon in a female population: prevalence and association with other conditions. Angiology 1987;38:871-7.
15. Wagner U, Pierer M, Kaltenhäuser S, et al. Clonally expanded CD4+CD28null T cells in rheumatoid arthritis use distinct combinations of T cell receptor BV and BJ elements. Eur J Immunol 2003;33:79-84.
16. Chikanza IC, Stein M, Lutalo S, Gibson T. The clinical, serological and radiological features of rheumatoid arthritis in ethnic black Zambabwean and British Caucasian patients. J Rheumatol 1994;21:2011-5.